2016
DOI: 10.18632/oncotarget.7082
|View full text |Cite
|
Sign up to set email alerts
|

Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice

Abstract: This study aimed to identify gastric mucosal protectants that suppress intestinal tumorigenesis in a mouse model. We chose six gastric mucosal protectants (ecabet sodium hydrate, irsogladine maleate, rebamipide, sofalcone, teprenone and troxipide) and examined their effects on the activity of oxidative stress-related transcriptional factors, including AP-1, NF-jB, NRF2, p53 and STAT3, in Caco-2 cells using a luciferase reporter gene assay. Among the six protectants, irsogladine maleate clearly inhibited NF-jB … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 29 publications
0
16
0
Order By: Relevance
“…Therefore, IL-6 reduction is likely involved in the polyp suppressive effects of acetazolamide. In another experiment that we previously performed, IL-6 played an important role in the development of intestinal polyps in Min mice [ 14 , 15 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, IL-6 reduction is likely involved in the polyp suppressive effects of acetazolamide. In another experiment that we previously performed, IL-6 played an important role in the development of intestinal polyps in Min mice [ 14 , 15 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…A π–π stacking of the 5‐ASA aromatic ring with His144 residue of Chain A could also be observed. It is worth noting that irsogladine has been shown chemopreventive properties by significantly reducing number of intestinal polyp in a mouse model [62] …”
Section: Discussionmentioning
confidence: 99%
“…Recently, the use of endoscopy, a minimally invasive treatment technique that aids the diagnosis and treatment of gastrointestinal (GI) disorders, has rapidly expanded in the therapeutic eld. According to this growth of endoscopy application to meet the rising clinical demand, endoscopically injectable hydrogels have attracted attention for use in endoscopic submucosal dissection (ESD), hemostasis, mucus protection, and wound healing, among others (Onuma et al, 2016). ese hydrogels may be pre-formed or precursor liquid-type hydrogels, which form hydrogels at the applied site.…”
Section: Introductionmentioning
confidence: 99%